Michelle is the North American leader of the Life Sciences Valuation Modeling and Economics services and has experience in business and intangible asset valuations for pharmaceutical, biotechnology and medical device companies. This team provides analyses and determinations of fair value and fair market value, specific to the needs of the life sciences sector for a variety of purposes.
She has more than 15 years of experience as a valuation professional and has spent over half of that period fully dedicated to the life science sector’s valuation needs.
Michelle received her BA Hons in chemistry from Cambridge University, a PhD in chemistry from the State University of NY and an MBA from Boston College. She holds the CFA designation.
How Michelle is building a better working world
“I work with companies across the life sciences sector to understand the value of the assets that they acquire and develop, helping them optimize their portfolio and create greater shareholder value. My experience working with varied clients in the sector allows me to quickly identify opportunities to help my clients.”